Skip to main content

Atrophy, Facioscapulohumeral clinical trials at UCSD

1 in progress, 0 open to eligible people

Showing trials for
  • Phase 1/2 Study of AOC 1020 in Adults With Facioscapulohumeral Muscular Dystrophy (FSHD)

    Sorry, not currently recruiting here

    A Randomized, Double-blind, Placebo-controlled, Phase 1/2 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Exploratory Efficacy of AOC 1020 Administered Intravenously to Adult Participants with Facioscapulohumeral Muscular Dystrophy (FSHD)

    San Diego, California and other locations

Last updated: